title: Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.
abstract: The significance of catalytic autoantibodies abzymes in the pathogenesis of multiple sclerosis was evaluated in patients with different disease patterns and severity of disability.
authors.affiliation: Moscow Regional Research and Clinical Institute, Moscow, Russia.
authors.forename: V K
authors.initials: VK
authors.lastname: Misikov
authors.forename: M V
authors.initials: MV
authors.lastname: Kimova
authors.forename: O M
authors.initials: OM
authors.lastname: Durova
authors.forename: A G
authors.initials: AG
authors.lastname: Gabibov
authors.forename: S V
authors.initials: SV
authors.lastname: Suchkov
authors.forename: I I
authors.initials: II
authors.lastname: Vorobev
authors.forename: N A
authors.initials: NA
authors.lastname: Ponomarenko
mesh_terms: D000328:Adult; D017151:Antibodies, Catalytic / Q000097:blood* / Q000134:cerebrospinal fluid; D001323:Autoantibodies / Q000097:blood* / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D004676:Myelin Basic Protein / Q000276:immunology*; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000276:immunology*; D063308:Myelin-Oligodendrocyte Glycoprotein
chemical_list: D017151:Antibodies, Catalytic; D001323:Autoantibodies; C571326:MOG protein, human; D004676:Myelin Basic Protein; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein